Kestra Medical Technologies (KMTS) Gains from Investment Securities (2025 - 2026)

Kestra Medical Technologies' (KMTS) quarterly Gains from Investment Securities came in at -$376000.0 in Q2 2026, down 62.07% on a QoQ basis from -$232000.0 in Q1 2026.

Kestra Medical Technologies (KMTS) Gains from Investment Securities (2025 - 2026) Analysis & Trends

Kestra Medical Technologies (KMTS) has 2 years of Gains from Investment Securities data on file, last reported at -$376000.0 in Q2 2026.

  • On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to -$376000.0 in Q2 2026; TTM through Apr 2026 was -$2.7 million, a N/A change from a year earlier, with the FY2026 full-year figure at -$2.7 million, down 200.94% from the prior year.
  • Gains from Investment Securities for Q2 2026 stood at -$376000.0, down from -$232000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for KMTS reached as high as $844000.0 in Q4 2025 and fell as low as -$2.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 126.32 Bn 121.10 Bn 1.96 Bn
2 Becton Dickinson 44.69 Bn 43.88 Bn 2.15 Bn
3 Alcon 32.80 Bn 31.14 Bn 1.53 Bn
4 Medline 32.72 Bn 30.49 Bn 1.84 Bn
5 Resmed 29.54 Bn 27.88 Bn 890.98 Mn
6 West Pharmaceutical Services 23.56 Bn 23.13 Bn 329.20 Mn
7 Solventum 14.00 Bn 13.44 Bn 1.10 Bn
8 Cooper Companies 13.75 Bn 13.61 Bn 735.40 Mn
9 Align Technology 12.03 Bn 10.97 Bn 736.59 Mn
10 Kestra Medical Technologies 1.23 Bn 869.98 Mn 15.68 Mn

Historic Data

Download Data
DateValue
Apr 30, 2026 -376,000.00
Apr 30, 2026 -376,000.00
Jan 31, 2026 -232,000.00
Jan 31, 2026 -232,000.00
Oct 31, 2025 844,000.00
Oct 31, 2025 844,000.00
Jul 31, 2025 -2.91 Mn
Jul 31, 2025 -2.91 Mn